Published in World J Gastroenterol on September 28, 2005
Acute colonic pseudoobstruction. Clin Colon Rectal Surg (2015) 0.77
Decrease of guanylyl cyclase β1 subunit and nitric oxide (NO)-induced relaxation in mouse rectum with colitis and its reproduction on long-term NO treatment. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.75
Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev (1991) 42.38
Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology (1989) 7.59
Increased nitric oxide synthesis in ulcerative colitis. Lancet (1993) 3.81
Observations on idiopathic proctitis. Gut (1962) 2.78
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet (1993) 2.20
In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur J Pharmacol (1993) 1.98
A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor. Life Sci (1992) 1.56
Enteric inhibitory neural regulation of human colonic circular muscle: role of nitric oxide. Gastroenterology (1993) 1.54
Projections and chemical coding of neurons with immunoreactivity for nitric oxide synthase in the guinea-pig small intestine. Neurosci Lett (1992) 1.49
Colonic motility and transit in health and ulcerative colitis. Gastroenterology (1991) 1.45
Toxic megacolon. Lancet (1998) 1.31
Defect in colonic smooth muscle contraction in patients with ulcerative colitis. Am J Physiol (1991) 1.14
Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat. Gastroenterology (1995) 1.11
Altered myoelectrical activity in noninflamed ileum of rats with colitis induced by trinitrobenzene sulphonic acid. Neurogastroenterol Motil (1999) 1.02
Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis. Br J Pharmacol (2003) 1.01
Modulation of cholinergic and substance P-like neurotransmission by nitric oxide in the guinea-pig ileum. Br J Pharmacol (1993) 1.01
Abnormal gastrocolonic response in patients with ulcerative colitis. Gut (1980) 1.00
Glucocorticoid-induced gastric mucosal damage: inhibition of leukotriene, but not prostaglandin biosynthesis. Prostaglandins (1987) 1.00
Multiple organ dysfunction in ulcerative colitis. Am J Gastroenterol (2000) 0.98
Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase. Am J Physiol (1996) 0.97
Nitric oxide and inflammation: the answer is blowing in the wind. Nat Med (1997) 0.97
Role of inflammatory mediators in colonic smooth muscle function in ulcerative colitis. Dig Dis Sci (1988) 0.96
Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterology (1995) 0.95
Substance P and calcitonin gene-related peptide (CGRP) in gastrointestinal inflammation. Ann N Y Acad Sci (1992) 0.95
Small bowel gas in severe ulcerative colitis. Gut (1991) 0.90
Toxic megacolon in ulcerative colitis and Crohn's colitis. Clin Gastroenterol (1980) 0.90
Early recognition of toxic megacolon. J Clin Gastroenterol (1987) 0.89
Effect of 2,4,6-trinitrobenzenesulphonic acid (TNBS)-induced ileitis on the motor function of non-inflamed rat gastric fundus. Neurogastroenterol Motil (2001) 0.88
Nitric oxide affects mammalian distal colonic smooth muscle by tonic neural inhibition. Br J Pharmacol (1993) 0.88
Effect of acute experimental colitis on rabbit colonic smooth muscle. Am J Physiol (1986) 0.86
Spontaneous contractions and some electrophysiologic properties of circular muscle from normal sigmoid colon and ulcerative colitis. Gastroenterology (1988) 0.85
Specialization of tachykinin NK1 and NK2 receptors in producing fast and slow atropine-resistant neurotransmission to the circular muscle of the guinea-pig colon. Neuroscience (1994) 0.83
Role of non-adrenergic non-cholinergic inhibitory nerves in the colon of patients with ulcerative colitis. J Gastroenterol (1998) 0.82
GI distension in severe ulcerative colitis. Am J Gastroenterol (2002) 0.81
Role of nitric oxide in immune-mediated diseases. Clin Sci (Lond) (1996) 0.81
Prevalence of proximal faecal stasis in active ulcerative colitis. Gut (1991) 0.80
Tachykinin receptors mediate atropine-resistant rat duodenal reflex contractions in vivo. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.79
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice. Endocr Relat Cancer (2006) 2.04
Anemia of chronic disease and defective erythropoietin production in patients with celiac disease. Haematologica (2008) 1.72
Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci (2002) 1.28
Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis Colon Rectum (2003) 1.23
Flavonoids, vascular function and cardiovascular protection. Curr Pharm Des (2009) 1.16
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis (2002) 1.12
Cellular and molecular mechanisms of intestinal fibrosis. World J Gastroenterol (2012) 1.07
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro. Int J Oncol (2007) 1.03
Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis (2010) 1.02
Oxidative stress and endothelial dysfunction: say NO to cigarette smoking! Curr Pharm Des (2010) 1.01
Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. Am J Gastroenterol (2005) 1.00
Tea, flavonoids, and nitric oxide-mediated vascular reactivity. J Nutr (2008) 0.99
Arf6: a new player in FcgammaRIIIA lymphocyte-mediated cytotoxicity. Blood (2005) 0.98
Prevention of fibrosis in experimental colitis by captopril: the role of tgf-beta1. Inflamm Bowel Dis (2004) 0.98
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models. Endocr Relat Cancer (2009) 0.95
Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells. Prostate (2004) 0.94
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination. Thromb Haemost (2005) 0.93
Detection of alkaline sphingomyelinase activity in human stool: proposed role as a new diagnostic and prognostic marker of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2005) 0.91
TNFalpha downregulates PPARdelta expression in oligodendrocyte progenitor cells: implications for demyelinating diseases. Glia (2003) 0.90
Serum bFGF and VEGF correlate respectively with bowel wall thickness and intramural blood flow in Crohn's disease. Inflamm Bowel Dis (2004) 0.90
Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer. Endocr Relat Cancer (2007) 0.89
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro. Int J Cancer (2005) 0.89
Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors. Prostate (2008) 0.89
The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter (2004) 0.89
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells. Eur J Cancer (2006) 0.88
Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells. Oncol Rep (2012) 0.87
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells. Endocr Relat Cancer (2008) 0.87
Doppler enhancement after intravenous levovist injection in Crohn's disease. Inflamm Bowel Dis (2002) 0.86
Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase. PLoS One (2011) 0.86
Evaluation of metastatic potential in prostate carcinoma: an in vivo model. Int J Oncol (2004) 0.85
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer. Endocr Relat Cancer (2013) 0.85
Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells. J Immunol (2002) 0.84
Current management of severe ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol (2007) 0.84
Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells. Oncol Rep (2007) 0.84
Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease. Cytotherapy (2009) 0.84
Monthly and seasonal birth patterns and the occurrence of Crohn's disease. Am J Gastroenterol (2009) 0.84
Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing. J Crohns Colitis (2011) 0.83
Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats. Can J Gastroenterol (2012) 0.82
Peristalsis regulation by tachykinin NK1 receptors in the rabbit isolated distal colon. Am J Physiol Gastrointest Liver Physiol (2003) 0.81
Anti-vascular endothelial growth factor activity in the bevacizumab and triamcinolone acetonide combination for intravitreal use. Eur J Ophthalmol (2009) 0.81
Mouse Sertoli cells sustain de novo generation of regulatory T cells by triggering the notch pathway through soluble JAGGED1. Biol Reprod (2014) 0.81
GI distension in severe ulcerative colitis. Am J Gastroenterol (2002) 0.81
TLR4 and TLR9 Expression in Different Phenotypes of Rhinitis. Int J Otolaryngol (2012) 0.80
Induction of apoptosis by quercetin: different response of human chronic myeloid (K562) and acute lymphoblastic (HSB-2) leukemia cells. Mol Cell Biochem (2006) 0.80
Effect of vaginal probiotic lactobacilli on in vitro-induced sperm lipid peroxidation and its impact on sperm motility and viability. Fertil Steril (2011) 0.80
Immunophenotypic characterization of human glioblastoma stem cells: correlation with clinical outcome. J Cell Biochem (2015) 0.80
Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models. Anticancer Agents Med Chem (2014) 0.80
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms. Digestion (2015) 0.80
Education and Imaging: gastrointestinal: eosinophilic ascites. J Gastroenterol Hepatol (2012) 0.79
In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma. Prostate (2007) 0.79
Hypoxia modulation of peroxisome proliferator-activated receptors (PPARs) in human glioblastoma stem cells. Implications for therapy. J Cell Biochem (2012) 0.79
Surgical and biologic outcomes after neoadjuvant bicalutamide treatment in prostate cancer. Urology (2007) 0.79
Smad3 knock-out mice as a useful model to study intestinal fibrogenesis. World J Gastroenterol (2006) 0.79
A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. BMC Gastroenterol (2014) 0.79
Long-standing intestinal lymphangiectasia detected by double-balloon enteroscopy. Clin Gastroenterol Hepatol (2011) 0.79
Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia. J Cancer Res Clin Oncol (2004) 0.79
Impact of platelet phenotype on myocardial infarction. Biomarkers (2014) 0.79
Ganglioside GM3 activates ERKs in human lymphocytic cells. J Lipid Res (2002) 0.79
Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp Dermatol (2003) 0.78
The long journey of salicylates in ulcerative colitis: The past and the future. J Crohns Colitis (2009) 0.78
PDE-5 and NOS II mRNA expression in menopausal women: a molecular biology study. World J Urol (2010) 0.78
Neuroendocrine transdifferentiation induced by VPA is mediated by PPARgamma activation and confers resistance to antiblastic therapy in prostate carcinoma. Prostate (2008) 0.77
Her2 crosstalks with TrkA in a subset of prostate cancer cells: rationale for a guided dual treatment. Prostate (2009) 0.77
Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures. Anticancer Res (2003) 0.76
Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis. Inflamm Bowel Dis (2016) 0.76
Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients. Oncol Rep (2007) 0.76
Treatment of inflammatory bowel diseases: to heal the wound or to heal the sick? J Crohns Colitis (2012) 0.76
Therapeutic application of stem cells in gastroenterology: an up-date. World J Gastroenterol (2011) 0.76
In vitro evaluation of different methods of handling human liposuction aspirate and their effect on adipocytes and adipose derived stem cells. J Cell Physiol (2015) 0.76
Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples. Int J Oncol (2005) 0.76
Clinical course of late-onset Crohn's disease. Inflamm Bowel Dis (2009) 0.75
Persistent human cosavirus infection in lung transplant recipient, Italy. Emerg Infect Dis (2013) 0.75
Changes in Hematologic and Coagulation Profiles in Rabbits with Right-ventricle Pacing. Folia Med (Plovdiv) (2016) 0.75
Multifrequency ultrasound-assisted liposuction: 5 years of experience. Aesthetic Plast Surg (2012) 0.75
Human herpes virus-6 chromosomal integration misled the management of Crohn's disease. Inflamm Bowel Dis (2011) 0.75
Association between vasomotor rhinitis and irritable bowel syndrome. Allergy Rhinol (Providence) (2016) 0.75
Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells. J Cancer Res Clin Oncol (2005) 0.75
Academic success or failure in nursing students: results of a retrospective observational study. Nurse Educ Today (2013) 0.75
Colonic involvement in celiac disease and possible implications of the sigmoid mucosa organ culture in its diagnosis. J Clin Immunol (2013) 0.75
Mucosal changes induced by ischemia-reperfusion injury in a jejunal loop transplanted in oropharynx. Intern Emerg Med (2011) 0.75
Features of intestinal lesions in the clinical course of inflammatory bowel diseases. Ital J Anat Embryol (2014) 0.75
Effects of dutasteride on prostate carcinoma primary cultures: a comparative study with finasteride and MK386. J Urol (2008) 0.75
Historical evolution of the management of severe ulcerative colitis. J Crohns Colitis (2008) 0.75
Advances in the pathogenesis of inflammatory bowel diseases: Capri 2010. Expert Rev Clin Immunol (2010) 0.75
TCRβ clonality improves diagnostic yield of TCRγ clonality in refractory celiac disease. J Clin Gastroenterol (2012) 0.75